Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

TAKASAGO INTERNATIONAL

SAKATA INX

Nichi-Iko Pharmaceutical

Milbon

TAIYO HOLDINGS

東京応化工業

TOAGOSEI CO

kyowa Hakko Kirin

MANDOM

小林製薬

栄研化学

KANEKA

Dr.Ci:Labo

Noevir Holdings

SATO PHARMACEUTICAL

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: TAKASAGO INTERNATIONAL (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: TAKASAGO INTERNATIONAL (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	2.81% (-12.05%)	2.06% (-0.50%)	3.46% (1.53%)	1.56% (-1.67%)	3.92% (3.05%)
C/F margin (Industry Average)	8.18% (-3.31%)	8.00% (8.51%)	8.08% (7.04%)	6.06% (6.35%)	4.81% (8.25%)
ROA (Industry Average)	2.84% (0.52%)	1.95% (1.04%)	3.33% (2.07%)	1.50% (0.06%)	3.54% (2.71%)
ROE (Industry Average)	6.89% (-1.43%)	4.38% (0.03%)	7.56% (2.96%)	3.35% (4.68%)	7.62% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	6.49% (5.01%)	-2.48% (2.61%)	0.38% (-0.40%)	16.00% (8.16%)
Sales growth (Industry Average)	- (-)	-7.76% (-2.67%)	0.44% (5.36%)	-1.03% (1.07%)	4.65% (2.24%)
Net profit growth (Industry Average)	- (-)	-32.32% (203.46%)	68.38% (63.25%)	-55.47% (3.89%)	163.41% (90.38%)
Operating C/F growth (Industry Average)	- (-)	-9.78% (275.10%)	1.50% (35.09%)	-25.83% (-6.09%)	-16.92% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	41.31% (53.80%)	44.68% (54.51%)	44.10% (55.00%)	44.87% (53.59%)	46.52% (56.30%)
Liquidity ratio (Industry Average)	138.09% (217.72%)	138.99% (225.70%)	149.24% (237.55%)	150.50% (239.89%)	159.33% (236.21%)
C/F ratio current liabilities (Industry Average)	477.94% (777.21%)	500.61% (303.31%)	475.73% (434.79%)	635.29% (929.73%)	814.88% (573.30%)
Quick ratio (Industry Average)	68.00% (138.97%)	71.23% (148.85%)	77.06% (156.17%)	80.51% (160.84%)	86.16% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	65.20day (83.89day)	71.62day (94.27day)	69.66day (93.96day)	77.17day (97.92day)	82.39day (98.27day)
Inventory turnover (Industry Average)	92.19day (54.45day)	90.27day (52.58day)	92.83day (52.64day)	91.58day (56.59day)	96.09day (58.68day)
Payable turnover (Industry Average)	34.75day (45.01day)	30.98day (49.82day)	36.92day (49.52day)	36.93day (52.10day)	36.85day (51.12day)
Working capita turnover (Industry Average)	122.65day (93.32day)	130.91day (97.02day)	125.57day (97.08day)	131.82day (102.41day)	141.63day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	3.49% (34.57%)	-9.52% (1.49%)	-14.47% (-3.85%)	31.28% (21.16%)
Dividend Yield (Industry Average)	1.88% (3.20%)	1.63% (1.93%)	2.07% (2.17%)	2.16% (2.45%)	1.72% (2.07%)
PER (Industry Average)	14.03% (25.22%)	21.46% (23.06%)	11.53% (16.22%)	22.15% (29.19%)	11.04% (16.58%)
PBR (Industry Average)	0.96% (0.86%)	0.94% (1.06%)	0.87% (1.04%)	0.74% (0.95%)	0.84% (1.08%)
PCFR (Industry Average)	4.83% (7.18%)	5.54% (9.23%)	4.94% (-2.43%)	5.70% (9.50%)	9.01% (7.56%)
PSR (Industry Average)	0.39% (0.77%)	0.44% (0.88%)	0.40% (1.10%)	0.34% (0.90%)	0.43% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	2.99% (-27.66%)	4.10% (-4.34%)	2.94% (-5.37%)	3.25% (-10.69%)	3.97% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	2.06% (0.52%)	2.68% (0.92%)	1.84% (1.42%)	2.02% (-0.27%)	2.31% (1.53%)
ROE (Industry Average)	4.98% (-0.84%)	6.07% (-0.46%)	4.17% (1.81%)	4.41% (3.42%)	5.01% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	6.93% (3.64%)	-0.51% (3.03%)	3.59% (0.04%)	7.47% (3.91%)
Sales growth (Industry Average)	- (-)	-4.93% (-3.48%)	-4.77% (6.70%)	-0.82% (0.75%)	0.13% (-1.74%)
Net profit growth (Industry Average)	- (-)	30.43% (166.48%)	-31.65% (43.48%)	9.50% (-47.04%)	22.15% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	41.52% (56.79%)	44.15% (57.65%)	44.17% (57.17%)	45.87% (55.93%)	46.07% (57.57%)
Liquidity ratio (Industry Average)	113.77% (337.22%)	110.06% (276.75%)	120.80% (266.94%)	124.78% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	53.96% (167.28%)	52.90% (183.78%)	59.74% (174.83%)	65.40% (228.06%)	- (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	89.05day (87.55day)	95.36day (98.39day)	93.10day (95.88day)	110.31day (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	80.99day (50.17day)	75.63day (48.43day)	83.93day (47.43day)	92.35day (50.67day)	- (38.21day)
Payable turnover (Industry Average)	59.78day (45.70day)	53.08day (51.63day)	59.44day (51.13day)	67.19day (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	110.26day (92.02day)	117.91day (95.19day)	117.59day (92.19day)	135.47day (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	3.49% (34.46%)	-9.52% (3.11%)	-14.47% (-3.30%)	31.28% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	23.47% (34.12%)	18.62% (27.80%)	24.66% (13.58%)	19.26% (22.26%)	20.70% (26.42%)
PBR (Industry Average)	1.17% (0.97%)	1.13% (1.21%)	1.02% (1.17%)	0.85% (1.08%)	1.03% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.70% (3.42%)	0.76% (4.34%)	0.72% (3.67%)	0.62% (4.37%)	0.82% (10.14%)

Financial Indicator Details: TAKASAGO INTERNATIONAL

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	2.81%	2.06%	3.46%	1.56%	3.92%
C/F margin	8.18%	8.00%	8.08%	6.06%	4.81%
ROA	2.84%	1.95%	3.33%	1.50%	3.54%
ROE	6.89%	4.38%	7.56%	3.35%	7.62%
Recurring margin	4.59%	4.89%	5.21%	3.78%	6.28%
EBIT margin	4.86%	4.58%	5.46%	4.07%	6.51%
EBITDA margin	8.80%	9.02%	10.03%	8.37%	10.39%
NOPAT margin	2.92%	2.74%	3.27%	2.44%	3.90%
Sales SG rates	71.80%	70.64%	69.54%	70.62%	69.49%
Sales SG&A rates	23.54%	24.60%	25.30%	25.87%	25.22%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	3.93%	4.44%	4.57%	4.30%	3.88%
Capital expenditures net sales ratio	-4.53%	-4.30%	-4.21%	-3.20%	-4.96%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-5.77%	18.98%	-7.67%	19.01%
Equity growth	-	6.49%	-2.48%	0.38%	16.00%
Total assets growth	-	-1.54%	-1.20%	-1.33%	11.89%
Sales growth	-	-7.76%	0.44%	-1.03%	4.65%
Net profit growth	-	-32.32%	68.38%	-55.47%	163.41%
Operating C/F growth	-	-9.78%	1.50%	-25.83%	-16.92%
Recurring profit growth	-	-1.73%	7.04%	-28.25%	73.95%
EBIT growth	-	-13.22%	19.75%	-26.23%	67.47%
EBITDA growth	-	-5.49%	11.72%	-17.39%	29.88%
NOPAT growth	-	-13.22%	19.75%	-26.23%	67.47%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	41.31%	44.68%	44.10%	44.87%	46.52%
Liquidity ratio	138.09%	138.99%	149.24%	150.50%	159.33%
C/F ratio current liabilities	477.94%	500.61%	475.73%	635.29%	814.88%
Quick ratio	68.00%	71.23%	77.06%	80.51%	86.16%
Fixed ratio	75.18%	68.99%	68.78%	66.22%	61.18%
D/E ratio	84.12%	74.44%	74.10%	68.79%	64.19%
Loan to Value Ratio	34.75%	33.26%	32.68%	30.87%	29.86%
Business investment C/F ratio	-55.35%	-53.82%	-52.15%	-52.90%	-103.24%
Liabilities with interest growth	-	-5.76%	-2.93%	-6.80%	8.25%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	31.87day	32.55day	38.56day	35.97day	40.91day
Receivables turnover	65.20day	71.62day	69.66day	77.17day	82.39day
Inventory turnover	92.19day	90.27day	92.83day	91.58day	96.09day
Fixed assets turnover	112.20day	118.87day	115.05day	112.35day	115.05day
Total asset turnover	361.20day	385.57day	379.21day	378.06day	404.21day
Payable turnover	34.75day	30.98day	36.92day	36.93day	36.85day
Capital turnover	27.22day	29.51day	29.38day	29.69day	28.37day
Equity turnover	149.23day	172.30day	167.26day	169.65day	188.05day
Working capita turnover	122.65day	130.91day	125.57day	131.82day	141.63day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 10 B	¥ 10 B	¥ 12 B	¥ 11 B	¥ 13 B
Accounts receivable-trade	¥ 22 B	¥ 22 B	¥ 21 B	¥ 24 B	¥ 26 B
Other Current Assets	¥ 56 B	¥ 53 B	¥ 53 B	¥ 54 B	¥ 60 B
Current Assets	¥ 66 B	¥ 63 B	¥ 65 B	¥ 65 B	¥ 74 B
Tangible Assets	¥ 38 B	¥ 37 B	¥ 36 B	¥ 34 B	¥ 37 B
Intangible Assets	¥ 3 B	¥ 4 B	¥ 3 B	¥ 2 B	¥ 2 B
Investment etc.	¥ 13 B	¥ 15 B	¥ 13 B	¥ 13 B	¥ 17 B
Total Assets	¥ 122 B	¥ 120 B	¥ 119 B	¥ 117 B	¥ 131 B
Current Liabilities	¥ 48 B	¥ 45 B	¥ 44 B	¥ 43 B	¥ 46 B
Fixed Liabilities	¥ 23 B	¥ 20 B	¥ 22 B	¥ 21 B	¥ 23 B
Liabilities with interest	¥ 42 B	¥ 40 B	¥ 39 B	¥ 36 B	¥ 39 B
Net Assets	¥ 50 B	¥ 53 B	¥ 52 B	¥ 52 B	¥ 61 B
Capital stock	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B
Capital surplus etc.	¥ 41 B	¥ 44 B	¥ 43 B	¥ 43 B	¥ 52 B
Liabilities and net assets	¥ 122 B	¥ 120 B	¥ 119 B	¥ 117 B	¥ 131 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 123 B	¥ 114 B	¥ 114 B	¥ 113 B	¥ 118 B
Cost of Sales	¥ 89 B	¥ 80 B	¥ 79 B	¥ 80 B	¥ 82 B
Gross profit	¥ 34 B	¥ 33 B	¥ 34 B	¥ 33 B	¥ 36 B
Other income	¥ 924 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
SG&A	¥ 29 B	¥ 28 B	¥ 29 B	¥ 29 B	¥ 30 B
Other expenses	¥ 3 B	¥ 3 B	¥ 2 B	¥ 3 B	¥ 3 B
Net income	¥ 3 B	¥ 2 B	¥ 3 B	¥ 1 B	¥ 4 B
Operating income	¥ 5 B	¥ 5 B	¥ 5 B	¥ 3 B	¥ 6 B
Ordinary Income	¥ 5 B	¥ 5 B	¥ 5 B	¥ 4 B	¥ 7 B
EBITDA	¥ 10 B	¥ 10 B	¥ 11 B	¥ 9 B	¥ 12 B
Income before income taxes	¥ 5 B	¥ 4 B	¥ 5 B	¥ 4 B	¥ 7 B
Depreciation	¥ 4 B	¥ 5 B	¥ 5 B	¥ 4 B	¥ 4 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 1 B	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 10 B	¥ 9 B	¥ 9 B	¥ 6 B	¥ 5 B
Investment CF	¥ -9 B	¥ -6 B	¥ -5 B	¥ -3 B	¥ -5 B
Financial CF	¥ 3 B	¥ -3 B	¥ -1 B	¥ -3 B	¥ 1 B
Foreign Exchange Effects	¥ -1 B	¥ 136 M	¥ -469 M	¥ -123 M	¥ 398 M
Net Change in Cash	¥ 3 B	¥ -459 M	¥ 1 B	¥ -931 M	¥ 2 B
Free CF	¥ 840 M	¥ 2 B	¥ 4 B	¥ 2 B	¥ 361 M
Capital expenditures	¥ -5 B	¥ -4 B	¥ -4 B	¥ -3 B	¥ -5 B
Cash dividends paid	¥ -923 M	¥ -828 M	¥ -955 M	¥ -851 M	¥ -892 M
Repayment loans	¥ -4 B	¥ -4 B	¥ -7 B	¥ -5 B	¥ -4 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -904 M	¥ -803 M	¥ -903 M	¥ -802 M	¥ -794 M
Net income	¥ 3 B	¥ 2 B	¥ 3 B	¥ 1 B	¥ 4 B
Purchase of treasury stock	¥ -16 M	¥ -8 M	¥ -10 M	¥ -400 M	¥ -11 M
Other Change in Stockholders Equity	¥ 1 M	-	-	¥ -1 M	¥ -1 M
Other Change in Net Assets	¥ -9 B	¥ 1 B	¥ -4 B	¥ -370 M	¥ 4 B
Net Change in Net Assets	¥ -6 B	¥ 3 B	¥ -1 B	¥ 201 M	¥ 8 B

Financial Indicator Details: TAKASAGO INTERNATIONAL

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	2.99%	4.10%	2.94%	3.25%	3.97%
C/F margin	-	-	-	-	-
ROA	2.06%	2.68%	1.84%	2.02%	2.31%
ROE	4.98%	6.07%	4.17%	4.41%	5.01%
Recurring margin	5.07%	6.66%	4.96%	5.79%	11.02%
EBIT margin	5.22%	6.86%	5.19%	6.06%	-
EBITDA margin	5.38%	7.02%	5.99%	6.87%	-
NOPAT margin	3.13%	4.11%	3.11%	3.63%	-
Sales SG rates	73.81%	71.62%	71.24%	71.32%	96.02%
Sales SG&A rates	21.92%	22.71%	24.80%	24.27%	-
Sales R&D expenses rates	6.53%	6.75%	6.88%	7.07%	-
Sales depreciation rates	0.15%	0.15%	0.80%	0.80%	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-18.18%	70.40%	-17.74%	-100.00%
Equity growth	-	6.93%	-0.51%	3.59%	7.47%
Total assets growth	-	0.57%	-0.55%	-0.24%	7.00%
Sales growth	-	-4.93%	-4.77%	-0.82%	0.13%
Net profit growth	-	30.43%	-31.65%	9.50%	22.15%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	24.99%	-29.12%	15.68%	90.74%
EBIT growth	-	24.82%	-28.00%	15.88%	-100.00%
EBITDA growth	-	23.94%	-18.71%	13.70%	-100.00%
NOPAT growth	-	24.82%	-28.00%	15.88%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	41.52%	44.15%	44.17%	45.87%	46.07%
Liquidity ratio	113.77%	110.06%	120.80%	124.78%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	53.96%	52.90%	59.74%	65.40%	-
Fixed ratio	48.25%	42.97%	40.94%	37.92%	-
D/E ratio	83.75%	77.41%	79.43%	68.48%	-
Loan to Value Ratio	34.78%	34.18%	35.09%	31.41%	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-1.16%	2.08%	-10.69%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	22.54day	19.40day	34.72day	28.79day	-
Receivables turnover	89.05day	95.36day	93.10day	110.31day	-
Inventory turnover	80.99day	75.63day	83.93day	92.35day	-
Fixed assets turnover	105.80day	106.01day	105.53day	102.09day	-
Total asset turnover	528.01day	558.61day	583.37day	586.80day	627.05day
Payable turnover	59.78day	53.08day	59.44day	67.19day	-
Capital turnover	48.35day	50.86day	53.41day	53.85day	-
Equity turnover	219.28day	246.66day	257.72day	269.19day	288.94day
Working capita turnover	110.26day	117.91day	117.59day	135.47day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 4 B	¥ 3 B	¥ 6 B	¥ 4 B	-
Accounts receivable-trade	¥ 17 B	¥ 17 B	¥ 16 B	-	-
Other Current Assets	¥ 40 B	¥ 39 B	¥ 38 B	¥ 40 B	-
Current Assets	¥ 44 B	¥ 43 B	¥ 44 B	-	-
Tangible Assets	¥ 20 B	¥ 19 B	¥ 18 B	¥ 17 B	-
Intangible Assets	¥ 497 M	¥ 2 B	¥ 1 B	¥ 1 B	-
Investment etc.	¥ 35 B	¥ 36 B	¥ 36 B	¥ 36 B	¥ 107 B
Total Assets	¥ 100 B	¥ 101 B	¥ 101 B	¥ 100 B	¥ 107 B
Current Liabilities	¥ 39 B	¥ 39 B	¥ 37 B	¥ 36 B	¥ 58 B
Fixed Liabilities	¥ 19 B	¥ 17 B	¥ 19 B	¥ 18 B	-
Liabilities with interest	¥ 35 B	¥ 34 B	¥ 35 B	¥ 31 B	-
Net Assets	¥ 41 B	¥ 44 B	¥ 44 B	¥ 46 B	¥ 49 B
Capital stock	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B	-
Capital surplus etc.	¥ 32 B	¥ 35 B	¥ 35 B	¥ 36 B	¥ 49 B
Liabilities and net assets	¥ 100 B	¥ 101 B	¥ 101 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 69 B	¥ 66 B	¥ 63 B	¥ 62 B	¥ 62 B
Cost of Sales	¥ 51 B	¥ 47 B	¥ 45 B	¥ 44 B	¥ 60 B
Gross profit	¥ 18 B	¥ 18 B	¥ 18 B	¥ 17 B	¥ 2 B
Other income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	-
SG&A	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	-
Other expenses	¥ 2 B	¥ 2 B	¥ 1 B	¥ 2 B	-
Net income	¥ 2 B	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B
Operating income	¥ 4 B	¥ 5 B	¥ 4 B	¥ 4 B	¥ 3 B
Ordinary Income	¥ 3 B	¥ 4 B	¥ 3 B	¥ 3 B	¥ 6 B
EBITDA	¥ 3 B	¥ 4 B	¥ 3 B	¥ 4 B	-
Income before income taxes	¥ 3 B	¥ 4 B	¥ 2 B	-	-
Depreciation	¥ 109 M	¥ 103 M	¥ 507 M	¥ 505 M	-
R&D expenses	¥ 4 B	¥ 4 B	¥ 4 B	-	-
Income taxes	¥ 1 B	¥ 1 B	¥ 1 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -904 M	¥ -803 M	¥ -903 M	-	-
Net income	¥ 2 B	¥ 2 B	¥ 1 B	-	-
Purchase of treasury stock	¥ -16 M	¥ -8 M	¥ -10 M	-	-
Other Change in Stockholders Equity	-	¥ -1 M	¥ -1 M	-	-
Other Change in Net Assets	¥ -2 B	¥ 995 M	¥ -1 B	-	-
Net Change in Net Assets	¥ -1 B	¥ 2 B	¥ -229 M	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: TAKASAGO INTERNATIONAL (Annual )

Statement Type

Annual : TAKASAGO INTERNATIONAL

First quarter : TAKASAGO INTERNATIONAL

Second quarter : TAKASAGO INTERNATIONAL

Third quarter : TAKASAGO INTERNATIONAL

Analysis Menu

Outline : TAKASAGO INTERNATIONAL

Statement : TAKASAGO INTERNATIONAL

Rating : TAKASAGO INTERNATIONAL

Indicator : TAKASAGO INTERNATIONAL

Download : TAKASAGO INTERNATIONAL

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo大田区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
TAKASAGO INTERNATIONAL	4914	TSE 1st	Chemicals	3	Annual	A

Related Company

TAKASAGO INTERNATIONAL (Sales ¥ 118 B)

TOYO INK SC HOLDINGS (Sales ¥ 248 B)

Dr.Ci:Labo (Sales ¥ 33 B)

Central Glass (Sales ¥ 173 B)

SAWAI PHARMACEUTICAL (Sales ¥ 80 B)

ZEON (Sales ¥ 250 B)

日本新薬 (Sales ¥ 69 B)

東京応化工業 (Sales ¥ 72 B)

TENMA (Sales ¥ 58 B)

NITTO FC (Sales ¥ 18 B)

Nichi-Iko Pharmaceutical (Sales ¥ 93 B)

日油 (Sales ¥ 148 B)

Sumitomo Bakelite (Sales ¥ 183 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .